Is OraSure Technologies Inc (OSUR) overvalued? · rev $185.8M
OraSure Technologies Inc (OSUR) is a medical instruments & supplies company listed on US.
This page asks whether OraSure Technologies Inc (OSUR) looks expensive on cached numbers — not a short thesis.
Latest reported OSUR revenue for 2024-12-31 was $185.8M. Net income was -$19.5M. Revenue was down 54.2% from 2023-12-31 to 2024-12-31. OSUR currently screens at market cap $225.1M.
OSUR currently screens at market cap $225.1M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OSUR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OSUR stock page for the full model, not this heading.
Not investment advice.